Anika Therapeutics, Inc. develops and commercializes hyaluronic acid-based products for orthopedic regenerative solutions and osteoarthritis pain management. Its offerings include advanced tissue repair products such as Integrity™ for rotator cuff repair, Hyalofast® for cartilage regeneration, and various non-opioid injections like Cingal® and Monovisc® for osteoarthritis treatment. The company serves healthcare providers and patients globally, with products available in over 45 countries, focusing on restoring mobility and enhancing quality of life.
- Website
- www.anika.com
- Issuer profile
- All listings